Evidence map›Paper›PMID 38851718›Full record

ArticleRadiation oncology (London, England)2024

Radiation pneumonitis prediction with dual-radiomics for esophageal cancer underwent radiotherapy.

Chenyu Li, Ji Zhang, Boda Ning, Jiayi Xu, Zhixi Lin, Jicheng Zhang, Ninghang Tan, Xianwen Yu, Wanyu Su, Weihua Ni and 6 more

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chenyu Li *Radiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Ji Zhang *Radiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Boda Ning *Radiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Jiayi XuRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zhixi LinRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Jicheng ZhangRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Ninghang TanRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Xianwen YuRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Wanyu SuRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Weihua NiRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Wenliang YuDepartment of Radiation Oncology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People' s Hospital, Quzhou, 324000, China.
Jianping WuDepartment of Radiation Oncology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People' s Hospital, Quzhou, 324000, China.
Guoquan CaoRadiological Department, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zhuo CaoDepartment of Respiratory, Lishui People's Hospital, Lishui, 323000, China. caozhuo1017@126.com.
Congying XieRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. wzxiecongying@163.com.
Xiance JinRadiotherapy Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. jinxc1979@hotmail.com.

Funding

the key project jointly built by the Provinces and Ministry of Zhejiang Health Commission 2021438235the key R & D project of the Department of Science and Technology of Zhejiang Province 2020C03028the Major project of Wenzhou Science and Technology Bureau ZY2020011Zhejiang Engineering Research Center for Innovation and Application of Intelligent Radiotherapy Technology ZY2022016Zhejiang Provincial Natural Science Foundation of China LTGY23H180010
6 · The paper itself

Abstract

backgroundTo integrate radiomics and dosiomics features from multiple regions in the radiation pneumonia (RP grade ≥ 2) prediction for esophageal cancer (EC) patients underwent radiotherapy (RT).

methodsTotal of 143 EC patients in the authors' hospital (training and internal validation: 70%:30%) and 32 EC patients from another hospital (external validation) underwent RT from 2015 to 2022 were retrospectively reviewed and analyzed. Patients were dichotomized as positive (RP+) or negative (RP-) according to CTCAE V5.0. Models with radiomics and dosiomics features extracted from single region of interest (ROI), multiple ROIs and combined models were constructed and evaluated. A nomogram integrating radiomics score (Rad_score), dosiomics score (Dos_score), clinical factors, dose-volume histogram (DVH) factors, and mean lung dose (MLD) was also constructed and validated.

resultsModels with Rad_score_Lung&Overlap and Dos_score_Lung&Overlap achieved a better area under curve (AUC) of 0.818 and 0.844 in the external validation in comparison with radiomics and dosiomics models with features extracted from single ROI. Combining four radiomics and dosiomics models using support vector machine (SVM) improved the AUC to 0.854 in the external validation. Nomogram integrating Rad_score, and Dos_score with clinical factors, DVH factors, and MLD further improved the RP prediction AUC to 0.937 and 0.912 in the internal and external validation, respectively.

conclusionCT-based RP prediction model integrating radiomics and dosiomics features from multiple ROIs outperformed those with features from a single ROI with increased reliability for EC patients who underwent RT.

Indexed as

Esophageal NeoplasmsNomogramsRadiation PneumonitisAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisRadiomicsRadiotherapy DosageRetrospective StudiesTomography, X-Ray ComputedDosiomicsEsophageal cancerRadiation pneumonitisRadiomics

Identifiers

PMID38851718
PMCPMC11161999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.